Medpace Logo

For Immediate Release: May 10, 2019

Julie Hopkins
513-579-9911 x 12627

Medpace Continues to Build Strong Network of UK Investigator Sites through its Flagship Site Programme

King’s Health Partners Receive Flagship Site Status

CINCINNATI, OH – (May 10, 2019) – Medpace (MEDP), a scientifically-driven, global full-service clinical research organization (CRO), announced that King’s Health Partners has achieved the status of a Flagship Site—the highest level of site certification in Medpace’s site relationship programme.

King’s Health Partners’ outstanding reputation in delivering world-class care and research drove the designation. With access to a patient population of eight million across South London and South East England and 22 Clinical Academic Groups, King’s Health Partners is well-aligned to collaborate with Medpace.

Medpace’s Flagship Site Programme was created to build and strengthen investigator/site relations to accelerate clinical development and to strengthen project deliverables. Only the highest-achieving sites who consistently demonstrate excellence in areas such as start up, recruitment, retention, and data quality are certified.

The partnership will increase King’s Health Partners access to innovative and cutting-edge trials being run by Medpace. By collaborating closely, Medpace and King’s Health Partners will work towards:

  • Increasing patient awareness and participation in new treatment options across South London and South East England;
  • Engaging Investigators, research nurses and patients at protocol development stage through to study closure to enhance study delivery and strategy, and;
  • Shorten study set-up timelines to deliver life changing therapeutics to patients faster.

“Medpace acknowledges King’s Health Partners as a leading Academic Health Sciences Centre and highly praises their vision of bringing together world-class research, education and clinical practice for the benefit of patients,” commented Andrew Masih, Medpace Executive Director. “In recognition of this, Medpace is pleased to announce the certification of King’s Health Partners as a Flagship Site. King’s Health Partners has shown great enthusiasm and commitment in delivering state-of-the-art trials. Their access to modern facilities will undoubtedly enable us to work together in successfully carrying out new and exciting studies.”

King’s Health Partners Flagship Certificate team picture
King’s Health Partners Team with their Medpace Flagship Site certificates

About Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,100 people across 36 countries.

About King’s Health Partners

King’s Health Partners Clinical Trials Office was set up as a joint initiative between King’s College London, Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospital NHS Foundation Trust and the South London and Maudsley NHS Foundation Trust to formalise the pre-existing collaborations between the partners, to develop their Clinical Trials potential and to increase the quality and delivery of commercially led clinical trials and academic/NHS led clinical trials. This initiative builds on their common commitment to strategic investment in translational research activities and aligns the partners with the Department of Health’s Initiatives that seek to increase the involvement of NHS staff and patients in health research and to increase industry investment in clinical research in the UK.

King’s Health Partners Academic Health Sciences Centre (AHSC) is a pioneering collaboration between King’s College London and Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts.

We work collectively to make sure that the lessons from research are used more swiftly, effectively and systematically to provide better and more joined up physical and mental health care for people. We also provide a unique combination of research, teaching and clinical expertise in addressing the relationship between mind and body.

Our partnership brings together:

  • three of the UK’s leading NHS Foundation Trusts
  • a world-leading university for health research and education
  • nearly 4.8 million patient contacts each year
  • 40,000 staff
  • nearly 30,000 students
  • a combined annual turnover of more than £3.7 billion.